相关实验视频

Updated: May 27, 2025

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance

Published on: July 21, 2023

人工直觉和加速抗微生物药物发现过程

Giovanni Stelitano¹, Christian Bettoni¹, Jacek Marczyk²

¹Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, 27100, Pavia, Italy.

Computers in biology and medicine

|February 15, 2025

概括

新的生物信息学工具加速了抗微生物药物开发. 人工直觉 (AI4) 和量化复杂性管理 (QCM) 分析化合物复杂性,指导合理的药物设计和降低成本.

科学领域:

药理学和化学信息学
药物发现和开发药物发现和开发
计算生物学计算生物学

背景情况:

开发抗微生物药物是昂贵和耗时的,而抗微生物耐药性的上升加剧了这种情况.
传统药物开发在效率和成本效益方面面临重大挑战.
生物信息学和人工智能 (AI) 为简化这一过程提供了潜在的解决方案.

研究的目的:

研究人工直觉 (AI4) 运用量化复杂性管理 (QCM) 分析抗菌化合物的实用性.
为了药物优化,探索化学复杂性和生物活性之间的关系.
评估AI4和QCM在加速合理药物设计方面的潜力.

主要方法:

使用AI4对Mycobacterium结核病活性化合物的药理学分析.
分子动态模拟 (MDS) 来生成化合物数据.
量化复杂性管理 (QCM) 用于从MDS输出中确定复杂性概况.

主要成果:

针对一系列抗微生物化合物的复杂性概况被生成.
发现了化学部分的复杂性与它们对生物活动的影响之间的相关性.
QCM成功地突出了与化合物疗效相关的关键化学特征.

结论:

与AI4集成的QCM显示出作为指导抗微生物药物优化的宝贵工具的前景.
这种方法可以显著帮助合理的药物设计,可能减少开发时间和成本.
由AI4驱动的QCM代表了未来药物发现工作的新策略.

关键词:

抗微生物化合物抗微生物化合物人工直觉是一种人工直觉.药物设计药物设计分子动力学分子动力学量化复杂性管理的管理方法

更多相关视频

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Antibiotic Selection

Antibiotic Selection

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...